Search results for "Influenza"

showing 10 items of 263 documents

Can influenza vaccination coverage among healthcare workers influence the risk of nosocomial influenza-like illness in hospitalized patients?

2013

Background Approximately 20% of healthcare workers are infected with influenza each year, causing nosocomial outbreaks and staff shortages. Despite influenza vaccination of healthcare workers representing the most effective preventive strategy, coverage remains low. Aim To analyse the risk of nosocomial influenza-like illness (NILI) among patients admitted to an acute care hospital in relation to influenza vaccination coverage among healthcare workers. Methods Data collected over seven consecutive influenza seasons (2005–2012) in an Italian acute care hospital were analysed retrospectively. Three different sources of data were used: hospital discharge records; influenza vaccination coverage…

Microbiology (medical)AdultMalemedicine.medical_specialtyAdolescentHealth PersonnelPopulationInfection controlSettore MED/42 - Igiene Generale E ApplicataRisk AssessmentYoung AdultAcute careHealth careInfluenza HumanmedicineInfection controlHumansIntensive care medicineeducationAgedRetrospective StudiesInfluenza-like illnesseducation.field_of_studyCross Infectionbusiness.industryIncidence (epidemiology)VaccinationGeneral MedicineMiddle AgedInfluenza vaccinationVaccinationInfectious DiseasesCross-Sectional StudiesItalyInfluenza VaccinesNosocomial influenzaVaccination coverageEmergency medicineHealthcare workerFemalebusiness
researchProduct

Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.

2013

Background. In most seasons, the influenza vaccine is effective in preventing influenza, but it is not clear whether it is equally effective in preventing mild and severe cases. We designed a case-control study to compare the effectiveness of the influenza vaccine in preventing outpatient, inpatient, and severe or fatal cases of laboratory-confirmed influenza. Methods. Hospitalized patients (n = 691) with laboratory-confirmed influenza in the 2010–2011 season recruited in 29 Spanish hospitals were individually matched by age, admission/visit date, and province with an outpatient with laboratory-confirmed influenza and an outpatient control. Severe cases were considered those patients admitt…

Microbiology (medical)AdultMalemedicine.medical_specialtyAdolescentInfluenza vaccineLower riskLogistic regressionYoung AdultPregnancyInternal medicineIntensive careInfluenza HumanOutpatientsmedicineHumansIntensive care medicineChildAgedAged 80 and overCross InfectionInpatientsbusiness.industryConfoundingInfant Newbornvirus diseasesInfantOdds ratioMiddle AgedPrognosisConfidence intervalVaccinationCommunity-Acquired InfectionsHospitalizationInfectious DiseasesInfluenza VaccinesSpainCase-Control StudiesChild PreschoolFemalebusinessClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C co…

2007

ABSTRACT We evaluated two formulations of a new combined Haemophilus influenzae type b (Hib)-meningococcal serogroup C (MenC)-tetanus toxoid (TT) conjugated vaccine and two formulations of a new MenC-TT vaccine (trials 711202/001 and 711202/008; clinical trial register numbers NCT00135486 and NCT00135564 [ www.ClinicalTrials.gov ]). A total of 520 healthy infants were randomized to receive primary vaccination (at 2, 3, and 4 months) with either MenC-TT plus diphtheria-tetanus-acellular pertussis (DTPa)-hepatitis B virus (HBV)-inactivated poliovirus (IPV)/Hib, Hib-MenC-TT plus DTPa-HBV-IPV, or MenC-CRM 197 plus DTPa-HBV-IPV/Hib (control). At 12 to 15 months, subjects received a polysaccharid…

Microbiology (medical)Clinical BiochemistryImmunologyPopulationMeningococcal VaccinesMeningococcal vaccineNeisseria meningitidis Serogroup CMeningococcal diseasemedicine.disease_causecomplex mixturesHaemophilus influenzaeAntigen-Antibody ReactionsConjugate vaccineImmunology and AllergyMedicineHumanseducationHaemophilus Vaccineseducation.field_of_studyAntigens BacterialReactogenicityVaccines Conjugatebusiness.industryNeisseria meningitidisInfantmedicine.diseaseVaccine ResearchVirologyAntibodies BacterialHaemophilus influenzaeVaccinationImmunologybusinessImmunologic MemoryClinical and vaccine immunology : CVI
researchProduct

Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenici…

2007

Microbiology (medical)Haemophilus InfectionsPenicillin binding proteinsmedicine.drug_classCephalosporinMicrobial Sensitivity TestsGene mutationmedicine.disease_causebeta-LactamasesMicrobiologyHaemophilus influenzaeAmp resistanceAmpicillinmedicineHumansPenicillin-Binding ProteinsPharmacology (medical)Mutationbusiness.industryGeneral MedicineHaemophilus influenzaeIn vitroCephalosporinsPhenotypeInfectious DiseasesSpainMutationAmpicillinbusinessAmpicillin Resistancemedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate …

2011

Background Induction of immunologic memory was assessed following primary vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Methods Infants were randomized (1:1) to receive 3 doses of PHiD-CV or 7vCRM (7-valent CRM197-conjugated pneumococcal conjugate vaccine [PCV]) at 2, 3, and 4 months of age followed by 23-valent pneumococcal polysaccharide vaccine (23vPS) booster dose at 11 to 14 months of age. Pneumococcal geometric mean antibody concentrations (GMCs) and opsonophagocytic activity (OPA) geometric mean titers were measured. Results Postprimary immune responses were consistent with those in previous PHiD-CV and 7vCRM studies…

Microbiology (medical)Heptavalent Pneumococcal Conjugate VaccineImmunization SecondaryBooster dosemedicine.disease_causecomplex mixturesPneumococcal conjugate vaccinePneumococcal InfectionsHaemophilus influenzaePneumococcal VaccinesConjugate vaccinemedicineHeptavalent Pneumococcal Conjugate VaccineHumansHepatitis B VaccinesVaccines CombinedDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleHaemophilus VaccinesVaccines Conjugatebusiness.industryVaccinationInfantOpsonin ProteinsPneumococcal polysaccharide vaccineAntibodies BacterialVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesStreptococcus pneumoniaeTreatment OutcomeImmunizationPediatrics Perinatology and Child HealthImmunologybusinessImmunologic Memorymedicine.drugThe Pediatric infectious disease journal
researchProduct

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D…

2009

Background The choice of non-typeable Haemophilus influenzae Protein D as main carrier protein in the candidate 10-valent pneumococcal conjugate vaccine (PHiD-CV, GlaxoSmithKline Biologicals), was driven in part to avoid carrier-mediated suppression and possible bystander interference with coadministered vaccines. Immunogenicity data from 3 primary and 2 booster vaccination studies were assessed for possible impacts of PHiD-CV coadministration on immune responses to routinely administered childhood vaccines, in comparison to 7-valent pneumococcal conjugate vaccine (7vCRM) coadministration. Methods Randomized, controlled studies in which PHiD-CV or 7vCRM vaccines were coadministered with DTP…

Microbiology (medical)Heptavalent Pneumococcal Conjugate VaccineLipoproteinsImmunization SecondaryMeningococcal VaccinesBooster dosemedicine.disease_causeAntibodies Viralcomplex mixturesPneumococcal conjugate vaccineHaemophilus influenzaePneumococcal VaccinesBacterial ProteinsConjugate vaccineHeptavalent Pneumococcal Conjugate VaccineMedicineHumansHepatitis B VaccinesVaccines CombinedDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleHaemophilus VaccinesRandomized Controlled Trials as TopicVaccines Conjugatebusiness.industryImmunization ProgramsDiphtheriaImmunogenicityVaccinationInfantImmunoglobulin Dmedicine.diseaseVirologyAntibodies BacterialVaccinationPoliovirus VaccinesInfectious DiseasesTreatment OutcomePediatrics Perinatology and Child HealthImmunologybusinessCarrier Proteinsmedicine.drugThe Pediatric infectious disease journal
researchProduct

Detection of respiratory viral infections in neonates treated for suspicion of nosocomial bacterial sepsis: a feasibility study.

2013

There is a lack of knowledge concerning the frequency and significance of respiratory viral infections that occur in the neonatal intensive care unit. In the present study, all neonates with suspected nosocomial bacterial sepsis were screened for a panel of respiratory viruses. Respiratory viral infections were detected in 10% of these cases. This was comparable with the frequency of a blood-culture-proven sepsis.

Microbiology (medical)Malemedicine.medical_specialtyNeonatal intensive care unitRhinovirusvirusesMEDLINEBacteremiaPilot Projectsmedicine.disease_causeInfant Newborn DiseasesSepsisInfluenza A Virus H1N1 SubtypeIntensive Care Units NeonatalInfluenza A virusmedicineHumansLack of knowledgeProspective StudiesRespiratory systemIntensive care medicineProspective cohort studyRespiratory Tract InfectionsCross Infectionbusiness.industryInfant Newbornmedicine.diseaseAnti-Bacterial AgentsRespiratory Syncytial VirusesBacterial sepsisInfectious DiseasesPediatrics Perinatology and Child HealthFeasibility StudiesFemalebusinessThe Pediatric infectious disease journal
researchProduct

Occurrence of a case of influenza A(H1N1)pdm09 and B co-infection during the epidemic season 2012–2013

2013

Abstract We report the detection of one case of co-infection with influenza A(H1N1)pdm09 and B, occurred during the 2012–2013 influenza season in Sicily. The dual infection was identified in a 18-year-old boy, who was not covered by specific vaccination and who had no other pre-existing risk factors. He presented classical symptoms of influenza-like illness developing no respiratory complications. A(H1N1)pdm09 viral concentration was initially about 10-fold higher than B virus, whereas its clearance was more rapidly achieved than in the case of B virus infection. Although influenza co-infection appears to be a rare event, a continued influenza surveillance activity is recommended, in order …

Microbiology (medical)Malemedicine.medical_specialtyRespiratory complicationsAdolescentMolecular Sequence DataBiologyInfluenza BSettore MED/42 - Igiene Generale E ApplicataMicrobiologyVirusInfluenza A Virus H1N1 SubtypeInfluenza HumanGeneticsmedicineInfluenza-like illnessHumansMolecular BiologySicilyEcology Evolution Behavior and SystematicsEpidemic seasonCoinfectionCo-infection Influenza; A(H1N1)pdm09; Influenza B; Influenza-like illnessPublic healthvirus diseasesInfluenza aVirologyVaccinationInfluenza B virusCo-infection InfluenzaInfectious DiseasesA(H1N1)pdm09ImmunologyEpidemiological MonitoringHuman mortality from H5N1Co infection
researchProduct

Comparison of the BD Directigen Flu A+B Kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and re…

2005

ABSTRACTThe Directigen Flu A+B enzyme immunoassay and the Abbott TestPack RSV enzyme immunoassay were each compared with a multiplex RT-PCR ELISA by testing 635 nasopharyngeal aspirates collected from children aged < 16 years who had been hospitalised with acute respiratory tract infection during the epidemic season 2002–2003. In this study, the sensitivity of the Directigen Flu A+B assay was unacceptably low (29.3% and 10.0%, respectively) for the detection of influenza A and B viruses. The sensitivity of the Abbott TestPack RSV assay (77.4%) was acceptable and in agreement with the multiplex RT-PCR ELISA.

Microbiology (medical)Paramyxoviridaerespiratory syncytial virusrespiratory tract infectionEnzyme-Linked Immunosorbent AssayPolymerase Chain ReactionSensitivity and Specificityinfluenza virusVirusAssaysMicrobiologyPneumovirinaeNasopharynxMultiplex polymerase chain reactionmedicineMultiplexProspective StudiesMononegaviralesbiologymedicine.diagnostic_testReverse Transcriptase Polymerase Chain Reactionvirus diseasesGeneral Medicinebiology.organism_classificationenzyme immunoassayVirologyInfluenza B virusInfectious Diseasesmultiplex RT-PCRInfluenza A virusRespiratory Syncytial Virus HumanImmunoassayReagent Kits DiagnosticViral diseaseClinical Microbiology and Infection
researchProduct

Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-…

2004

Background: Recently an increase in the number of invasive Haemophilus influenzae type b (Hib) cases was observed in the United Kingdom, which coincided with a temporary change from diphtheria-tetanus toxoids-wild-type pertussis to diphtheria-tetanus toxoids-acellular pertussis (DTaP) Hib vaccines. A study in Germany based on approximately 2 years of follow-up, estimated vaccine effectiveness (VE) of DTaP/Hib and DTaP-inactivated poliovirus/Hib combination vaccines against invasive Hib disease to be high. Objectives: To assess VE of DTaP-containing Hib vaccines against Hib in Germany with the use of extended follow-up of case surveillance and vaccine uptake. Subjects and Methods: Cases with…

Microbiology (medical)Pediatricsmedicine.medical_specialtyHaemophilus InfectionsBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinesmedicine.disease_causecomplex mixturesHaemophilus influenzaeCohort StudiesGermanymedicineHumansVaccines CombinedWhooping coughHaemophilus VaccinesRetrospective Studiesbusiness.industryTetanusDiphtheriaPoliovirusHaemophilus influenzae type bToxoidInfantbacterial infections and mycosesmedicine.diseaseVirologyPoliovirus VaccinesInfectious DiseasesCase-Control StudiesChild PreschoolPediatrics Perinatology and Child HealthEnterovirusbusinessPediatric Infectious Disease Journal
researchProduct